Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Amino Acids

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00726-013-1623-9PMID 24292102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translational proteomics in Alzheimer's disease and related disorders.

  2013cited by this paper
• Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

  2013cited by this paper
• Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.

  2013cited by this paper
• Mass spectrometrical identification of hippocampal NMDA receptor subunits NR1, NR2A-D and five novel phosphorylation sites on NR2A and NR2B.

  2012cited by this paper
• Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

  2012influential reference
• Profiling of the human monocytic cell secretome by quantitative label‐free mass spectrometry identifies stimulus‐specific cytokines and proinflammatory proteins

  2012cited by this paper
• AMPA receptors as drug targets in neurological disease – advantages, caveats, and future outlook

  2012cited by this paper
• Hippocampal levels of GluR1 and GluR2 complexes are modulated by training in the multiple T-Maze in C57BL/6J mice

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

  2011cited by this paper
• Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex.

  2010cited by this paper
• Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection

  2009cited by this paper
• OTOR-SKILL LEARNING IN A NOVEL RUNNING-WHEEL TASK IS EPENDENT ON D1 DOPAMINE RECEPTORS IN THE STRIATUM

  2008cited by this paper
• Gel-based mass spectrometric analysis of recombinant GABA(A) receptor subunits representing strongly hydrophobic transmembrane proteins.

  2008cited by this paper
• D1 and D2 Receptor Antagonist Injections in the Prefrontal Cortex Selectively Impair Spatial Learning in Mice

  2007cited by this paper
• Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

  2007cited by this paper
• The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007

  2007influential reference
• Regulatory mechanisms of AMPA receptors in synaptic plasticity

  2007cited by this paper
• Dopamine-mediated regulation of corticostriatal synaptic plasticity.

  2007cited by this paper
• Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes

  2007cited by this paper
• Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.

  2006cited by this paper
• Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons

  2006cited by this paper
• Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.

  2006cited by this paper
• Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.

  2006cited by this paper
• Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases

  2006cited by this paper
• Proteomic analysis of rat hippocampal plasma membrane: characterization of potential neuronal‐specific plasma membrane proteins

  2006cited by this paper
• Serotonin 1A receptors in the living brain of Alzheimer's disease patients.

  2006cited by this paper
• Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking

  2006cited by this paper
• Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

  2006cited by this paper
• Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis.

  2005cited by this paper
• Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons.

  2005cited by this paper
• Dopamine Receptor Stimulation Modulates AMPA Receptor Synaptic Insertion in Prefrontal Cortex Neurons

  2005cited by this paper
• Alzheimer's disease.

  2004cited by this paper
• Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

  2004cited by this paper
• Glutamatergic systems in Alzheimer's disease

  2003cited by this paper
• Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment

  2003cited by this paper
• Progressive degeneration of nonphosphorylated neurofilament protein‐enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9

  2003cited by this paper
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.

  2001cited by this paper
• Prolonged fear responses in mice lacking dopamine D1 receptor.

  2001cited by this paper
• α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity*

  2001cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Essential Role of D1 But Not D2 Receptors in the NMDA Receptor-Dependent Long-Term Potentiation at Hippocampal-Prefrontal Cortex Synapses In Vivo

  2000cited by this paper
• beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.

  2000cited by this paper
• The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning.

  2000cited by this paper
• Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease.

  2000cited by this paper
• Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

  1999cited by this paper
• α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease

  1999cited by this paper
• Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein

  1999cited by this paper
• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  1999cited by this paper
• Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

  1998cited by this paper
• Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity

  1998cited by this paper
• Glutamate‐, glutaminase‐, and taurine‐immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper

• The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis

  2024cites this paper
• Treadmill Exercise Facilitates Synaptic Plasticity in APP/PS1 Mice by Regulating Hippocampal AMPAR Activity

  2024cites this paper
• The relationship between long non-coding RNAs and Wnt/β-catenin signaling pathway in the pathogenesis of Alzheimer's disease.

  2023cites this paper
• Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer’s disease

  2017cites this paper
• Identifying significant gene‐environment interactions using a combination of screening testing and hierarchical false discovery rate control

  2016cites this paper
• Hippocampal receptor complexes paralleling LTP reinforcement in the spatial memory holeboard test in the rat.

  2015cites this paper